A new allosteric site in glycogen phosphorylase b as a target for drug interactions (Q27625112)

1

0 references

V T Skamnaki

2

0 references

K E Tsitsanou

3

0 references

N G Gavalas

4

0 references

L N Johnson

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

5

0 references

publication date

15 June 2000

0 references

published in

Structure

0 references

volume

8

0 references

page(s)

575-84

0 references

issue

6

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Deconstructing type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

The family of glycogen phosphorylases: structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Glycogen phosphorylase: control by phosphorylation and allosteric effectors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

The Control of Glycogen Metabolism in the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

The structure and regulation of protein phosphatases

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

The structure, role, and regulation of type 1 protein phosphatases

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Design of inhibitors of glycogen phosphorylase: a study of alpha- and beta-C-glucosides and 1-thio-beta-D-glucose compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 A resolution and 100 K: the role of the water structure and its contribution to binding

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Effects of novel analogues of D-glucose on glycogen phosphorylase activities in crude extracts of liver and skeletal muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Effects of C-1-substituted glucose analogue on the activation states of glycogen synthase and glycogen phosphorylase in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

N-Acetyl-beta-D-glucopyranosylamine 6-phosphate is a specific inhibitor of glycogen-bound protein phosphatase 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Indole-2-carboxamide inhibitors of human liver glycogen phosphorylase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Evolution of allosteric control in glycogen phosphorylase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to T state glycogen phosphorylase b

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Structural changes in glycogen phosphorylase induced by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

The allosteric transition of glycogen phosphorylase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Structural basis for the activation of glycogen phosphorylase b by adenosine monophosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Effects of commonly used cryoprotectants on glycogen phosphorylase activity and structure

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Comparison of the binding of glucose and glucose 1-phosphate derivatives to T-state glycogen phosphorylase b

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

Improved methods for building protein models in electron density maps and the location of errors in these models

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

PROCHECK: a program to check the stereochemical quality of protein structures

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021

The CCP4 suite: programs for protein crystallography

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900144-1

7 January 2021